This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In patients with ischemic cardiomyopathy (ICM), what is the long-term survival of revascularization associated with coronaryarterybypassgrafting (CABG) and percutaneous coronary intervention (PCI)?
Eagle looks at anticoagulation for post-operative atrial fibrillation after isolated coronaryarterybypassgrafting. He then examines a meta-analysis of invasive vs. conservative management of non-ST-elevation acute coronary syndromes with previous coronaryarterybypassgrafting.
What is the safety and efficacy of direct cardiac shockwave therapy (SWT) among patients with ischemic cardiomyopathy undergoing coronaryarterybypassgraft surgery (CABG)?
Currently, there is no optimal revascularisation strategy for patients with ischaemic cardiomyopathy despite suggestions that coronaryarterybypassgraft (CABG) may be superior to medical therapy in improving survival. However, CABG may be associated with substantial risk in HF subjects.
BackgroundCurrent guidelines recommend revascularization in patients with ischemic cardiomyopathy (ICM). Joinpoint regression and multivariable logistic regression analyses were performed to assess the annual percentage change in trends and predictors of the 30‐day mortality rate, respectively.
A 72-year-old man with severe coronaryartery disease (CAD) and coronaryarterybypassgrafting complicated by ischemic cardiomyopathy and ventricular tachycardia (VT) was referred for redo VT ablation.
Background:Obstructive sleep apnoea (OSA) is highly prevalent in patients with obstructive hypertrophic cardiomyopathy (oHCM), and the severity of OSA appears to worsen following septal myoectomy. The proportion of coronaryarterybypassgraft and valvular intervention were comparable between patients with and without OSA.
This study explores the roles of cTnI (cardiac troponin I) and CK-MB in hypertrophic cardiomyopathy (HCM).Methods:This Patients were excluded if they had undergone percutaneous coronary intervention or coronaryarterybypassgrafting, or had renal failure.
Patient underwent surgical closure of fistula and a 2-vessel coronaryarterybypassgraft surgery, with a LIMA pedicle graft to the LAD, and SV graft to the LCx.Postoperatively, patient was continued on medical therapy with improvement of symptoms.
In most cases, rather, the culprit is gross ischemia due to myocardial infarction, cardiomyopathy, or advanced coronaryartery disease. Unfortunately, today’s case is lacking any such diagnostics, thus I cannot say with certainty that the QT interval is, or is not, culpable in arrhythmogenesis. [1]
Troponins may be negative with very rapid reperfusion, or measured too late, or chronically elevated due to cardiomyopathy or renal failure. Angiograms may be negative due to spasm or thrombus lysis or small vessel disease, or it may be a type 2 MI.
Using the nationwide registries, we obtained information on admissions, prescriptions, educational length, and occupational status for both the AAS users and controls.
Background Takotsubo cardiomyopathy (TC) is an established differential diagnosis of myocardial infarction with non-obstructive coronaries with significant interest but limited data on prognostication. We reviewed the characteristics and in-hospital outcomes and developed a novel risk score for TC. to 1.66), p<0.001).
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-ArterialCoronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency CoronaryArteryBypassGrafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content